Patent CourtU.S. patent litigation reference

IPR estoppel

35 U.S.C. § 315(e); the petitioner is estopped from asserting in district court or before the USPTO any ground raised or reasonably could have been raised after a final written decision.

IPR estoppel is the price of admission to inter partes review. Once the PTAB issues a final written decision on a claim, the petitioner — and any real party in interest or privy — may not re-litigate in district court, the USPTO, or the ITC any invalidity ground that was raised or reasonably could have been raised during the IPR. The Federal Circuit's reading of "reasonably could have been raised" expanded sharply in 2022.

The rule

Section 315(e) of Title 35 imposes two parallel estoppels following an IPR final written decision. Subsection (e)(1) bars the petitioner, real party in interest, and privies from requesting or maintaining any subsequent USPTO proceeding — IPR, PGR, ex parte reexamination — on any ground that the petitioner raised or reasonably could have raised during the inter partes review. Subsection (e)(2) imposes an identical bar in any civil action arising under § 1338 of Title 28 and in any section 337 investigation before the International Trade Commission.

The estoppel attaches only when the Board issues a final written decision on the patentability of the challenged claims. Settlement before final written decision, denial of institution, or termination without a decision do not trigger § 315(e). Because the PTAB now institutes on all-or-nothing grounds following SAS Institute Inc. v. Iancu, 584 U.S. 357 (2018), every petition that proceeds to final written decision generates the full statutory estoppel as to all instituted claims and grounds.

Statutory and regulatory source

The statutory text is brief but consequential. Section 315(e)(1) provides:

The petitioner in an inter partes review of a claim in a patent under this chapter that results in a final written decision under section 318(a), or the real party in interest or privy of the petitioner, may not request or maintain a proceeding before the Office with respect to that claim on any ground that the petitioner raised or reasonably could have raised during that inter partes review.

Section 315(e)(2) applies the same standard — "raised or reasonably could have raised" — to civil actions under 28 U.S.C. § 1338 and to ITC investigations. The companion estoppel for post-grant review appears in § 325(e) and reaches the broader range of grounds available in PGR.

No implementing regulation in 37 C.F.R. Part 42 expands or interprets § 315(e); the contour of the estoppel has been worked out exclusively in case law.

The framework

Pre-2018 reading: Shaw and the institution-bound estoppel

The early Federal Circuit decision in Shaw Industries Group, Inc. v. Automated Creel Systems, Inc., 817 F.3d 1293 (Fed. Cir. 2016), construed § 315(e) narrowly. Decided when the Board still routinely engaged in partial institution, Shaw reasoned that grounds the Board had refused to institute were never part of the IPR and therefore could not have been "raised" within it. The court held that estoppel did not attach to non-instituted grounds. District courts widely followed Shaw, though some pushed back on its broader implications, and the case carved a substantial loophole: a petitioner could withhold or stage grounds and, in the event of a partial-institution decision, preserve them for district court.

The SAS turn

In SAS Institute Inc. v. Iancu, the Supreme Court invalidated partial institution and held that the Board must institute on every claim and every ground in the petition — or none. After SAS, Shaw's premise — that some grounds in the petition would not be part of the IPR — collapsed. Once a petition is instituted, every ground in the petition is in the proceeding.

The Caltech expansion

The Federal Circuit in California Institute of Technology v. Broadcom Ltd., 25 F.4th 976 (Fed. Cir. 2022), read SAS and § 315(e) together to overrule Shaw. The court held that estoppel applies not only to grounds actually raised in the petition but also to any ground that reasonably could have been raised — meaning any ground that a skilled searcher conducting a diligent search could have discovered and included in the petition. Caltech rejected the petition-bounded reading of "during" and gave the statute its natural breadth.

Under Caltech, an IPR petitioner who fails to include an available ground in the petition forfeits it: the ground neither was raised (it is missing from the petition) nor was unavailable to a diligent searcher (or it would not have been omitted). The result is a near-categorical estoppel against patents-and-printed-publications challenges in subsequent district court litigation by the same defendant.

Burden, timing, deadlines

The party asserting estoppel — typically the patent owner — bears the burden of showing that each contested ground was raised or that a skilled searcher conducting a diligent search reasonably could have discovered the prior art. The contours of the diligent-searcher standard remain disputed at the district-court level and turn on expert testimony about commercial search tools, foreign-language databases, and the cost-benefit of additional searching.

Estoppel attaches at the moment the PTAB issues its final written decision under § 318(a). Until that point, parallel district court invalidity contentions remain available. Once the decision issues, estoppel applies even while an appeal to the Federal Circuit is pending; reversal on appeal would lift the estoppel.

The estoppel binds the petitioner, any real party in interest, and any privy of the petitioner. The privity inquiry is fact-intensive and looks to control over the IPR, financial relationships, and indemnification arrangements. Co-defendants who declined to file their own IPRs are not automatically bound, but those who funded or controlled a petitioner's IPR may be.

Interaction with district court litigation

IPR estoppel reshapes the validity defenses available in subsequent litigation. After a final written decision, the petitioner-defendant is limited to validity defenses outside the IPR's jurisdiction:

Civil action estoppel

Section 315(e)(2) applies to "a civil action arising in whole or in part under section 1338 of title 28." The estoppel runs in any district court patent infringement action — the venue is irrelevant. A defendant in EDTX, WDTX, Delaware, or NDCA who proceeds through IPR to final written decision is estopped equally.

The ITC carve-out

Section 315(e)(2) explicitly extends to ITC section 337 investigations. But the ITC and the courts have read this differently from district court estoppel in several respects. Because the ITC's invalidity determinations have no claim-preclusive effect on subsequent district court litigation, and because the ITC retains jurisdiction over a wider universe of validity issues than the PTAB, ITC respondents commonly raise grounds — including prior physical products and § 112 challenges — that survive § 315(e) on their face.

The product art question

An open and frequently litigated question is whether prior art consisting of a physical product, where corresponding patents or publications describing the product also exist, is foreclosed by IPR estoppel. District court authority is split: some courts hold that the underlying physical product is a separate ground and is not estopped; others reason that, where the publication discloses the same invalidating subject matter, the publication ground reasonably could have been raised in IPR and the product evidence is therefore cumulative and effectively estopped. The Federal Circuit has not yet given a definitive answer.

Practical notes

Open questions

See also

Authorities

Statutes and rules

  • 35 U.S.C. § 315(e) (IPR estoppel)
  • 35 U.S.C. § 318(a) (final written decision)
  • 35 U.S.C. § 325(e) (parallel PGR estoppel)
  • 28 U.S.C. § 1338 (district court patent jurisdiction)
  • 19 U.S.C. § 1337 (ITC investigations)

Cases

  • Shaw Industries Group, Inc. v. Automated Creel Systems, Inc., 817 F.3d 1293 (Fed. Cir. 2016)
  • California Institute of Technology v. Broadcom Ltd., 25 F.4th 976 (Fed. Cir. 2022)
  • SAS Institute Inc. v. Iancu, 584 U.S. 357 (2018)
  • United States v. Arthrex, Inc., 594 U.S. 1 (2021)

Last reviewed: 2026